Talk Regulatory Strategy & EU Pharmaceutical Policy track
S0906 - Paediatric Medicines in the EU and Global Contexts: Latest Developments
Thu, Mar 20, 2025 · 8:30–9:40 AM CET Boston 1-2 Room, Congress Center Basel
About this session
The ongoing revision of the EU Pharmaceutical Legislation is an opportunity to assess the EU Paediatric system, discuss ways to improve its implementation and promote increased global regulator collaboration in developing medicines for children. This session will provide an overview of the latest developments in the revision of the EU Paediatric legislation and explore existing initiatives aimed at achieving global harmonisation of development programs with international partners. Furthermore, case studies will be presented to highlight how current approaches can be optimised.
Programme:
- 2. New adapted paediatric investigation plans (PIPs) and mechanism of action PIPs — Sara Escola
- Panel Discussion — Ralph Bax
- 3. Paediatric Regulation Revision in the EU - Industry view — Jyothsna Krishnan
- 4. Paediatric medicines in the EU and Global context: Latest developments — Ralph Bax
- 1. Setting the scene — Angelika Joos
Speakers
-
Independent consultant · CRP International Strategy Consulting
Chair
